Pierfranco Conte

Pierfranco Conte

UNVERIFIED PROFILE

Are you Pierfranco Conte?   Register this Author

Register author
Pierfranco Conte

Pierfranco Conte

Publications by authors named "Pierfranco Conte"

Are you Pierfranco Conte?   Register this Author

100Publications

2567Reads

16Profile Views

Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?

Crit Rev Oncol Hematol 2019 Jun 6;138:87-103. Epub 2019 Apr 6.

Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2019.03.012DOI Listing
June 2019

Alpelisib for -Mutated, Hormone Receptor-Positive Advanced Breast Cancer.

N Engl J Med 2019 05;380(20):1929-1940

From Institut Gustave Roussy, INSERM Unité 981, Université Paris-Sud, Villejuif (F.A.), Institut de Cancérologie de l'Ouest, St. Herblain (M.C.), and Novartis Pharma, Paris (A.-S.L.) - all in France; Hospital Universitario 12 de Octubre, Madrid (E.C.); National Institute of Oncology (G.R.) and Duna Medical Center (Z.P.), Budapest, Hungary; German Breast Group, Neu-Isenburg, and Center for Hematology and Oncology Bethanien, Frankfurt - both in Germany (S.L.); UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.); Aichi Cancer Center, Nagoya (H.I.), Kanagawa Cancer Center, Yokohama (T.Y.), Saitama Cancer Center, Saitama (K.I.), and National Hospital Organization Hokkaido Cancer Center, Sapporo (M.T.) - all in Japan; Istituto Oncologico Veneto and the Departments of Surgery, Oncology, and Gastroenterology, University of Padua, Padua, Italy (P.C.); Vanderbilt University, Nashville (I.A.M.); Chaim Sheba Medical Center, Tel Hashomer, Israel (B.K.); National Taiwan University Hospital, Taipei (Y.-S.L.); Novartis Pharma, Basel, Switzerland (D.M., C.W.); Novartis Pharmaceuticals, East Hanover, NJ (S.H.); and Massachusetts General Hospital Cancer Center, Boston (D.J.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1813904
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1813904DOI Listing
May 2019

LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer.

Int J Mol Sci 2019 Apr 16;20(8). Epub 2019 Apr 16.

Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV- IRCCS, 35128 Padova, Italy.

View Article

Download full-text PDF

Source
https://www.mdpi.com/1422-0067/20/8/1874
Publisher Site
http://dx.doi.org/10.3390/ijms20081874DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514929PMC
April 2019

Therapeutic approaches for T790M mutation positive non-small-cell lung cancer.

Expert Rev Anticancer Ther 2018 10 14;18(10):1021-1030. Epub 2018 Aug 14.

c Coyote Research Group, Pangaea Oncology, Laboratory of Molecular Biology , Quirón-Dexeus University Institute , Barcelona , Spain.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1508347DOI Listing
October 2018

Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?

Crit Rev Oncol Hematol 2018 Aug 24;128:19-29. Epub 2018 May 24.

Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Via Gattamelata 64, 35128 Padova, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2018.05.013DOI Listing
August 2018

PARP Inhibitors in Breast Cancer: Why, How, and When?

Breast Care (Basel) 2018 Jul 20;13(3):216-219. Epub 2018 Jun 20.

Breast Cancer Unit, American Hospital of Paris, Neuilly-sur-Seine, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000490746DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062717PMC
July 2018

Olaparib for the treatment of breast cancer.

Expert Rev Anticancer Ther 2018 06 30;18(6):519-530. Epub 2018 Mar 30.

a Department of Surgery, Oncology and Gastroenterology , University of Padova , Padova , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1458613DOI Listing
June 2018

Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?

Crit Rev Oncol Hematol 2017 Nov 19;119:30-39. Epub 2017 Sep 19.

Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.09.007DOI Listing
November 2017

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.

N Engl J Med 2017 08 4;377(6):523-533. Epub 2017 Jun 4.

From the Memorial Sloan Kettering Cancer Center, New York (M.R.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Medical University of Gdańsk, Gdańsk, Poland (E.S.); National Cancer Center-Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (B.X.), and the First Hospital of Jilin University, Changchun (W.L.) - both in China; Basser Center, University of Pennsylvania, Philadelphia (S.M.D.); National Hospital Organization, Osaka National Hospital, Osaka, Japan (N.M.); Institut Gustave Roussy, Villejuif, France (S.D.); Beth Israel Deaconess Medical Center, Dana-Farber Harvard Cancer Center, Boston (N.T.); Christie Hospital NHS Foundation Trust and Faculty of Biology, Medicine and Health, University of Manchester, Manchester (A.A.), and AstraZeneca, Macclesfield (S.R.) - both in the United Kingdom; AstraZeneca, Gaithersburg, MD (W.W., C.G.); and University of Padua and Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1706450DOI Listing
August 2017

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.

Breast Cancer Res Treat 2017 06 13;163(2):295-302. Epub 2017 Mar 13.

Department of Surgery, Oncology and Gastroenterology, University of Padova, via Giustiniani 2, 35128, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4191-yDOI Listing
June 2017

Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients.

Nucl Med Commun 2017 Jun;38(6):537-545

aNuclear Medicine and Molecular Imaging Unit bBreast Surgery Unit cOncology 2 Unit, Veneto Institute of Oncology IOV - IRCCS dDepartment of Oncological and Surgical Sciences, Urology Clinic, University of Padua, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000671DOI Listing
June 2017

Biosimilars as a strategy to improve sustainability.

ESMO Open 2017 29;2(2):e000192. Epub 2017 May 29.

Department of Surgery, Oncology and Gastroenterology, University of Padua and Istituto Oncologico Veneto, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703382PMC
May 2017

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.

J Clin Oncol 2017 Jan 7;35(2):141-148. Epub 2016 Nov 7.

Edith A. Perez, Mayo Clinic, Jacksonville, FL; Howard Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Jennifer A. Petersen, Genentech, South San Francisco, CA; Carlos Barrios, Pontifícia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil; Wolfgang Eiermann, Interdisciplinary Oncology Center, Munich, Germany; Masakazu Toi, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Young-Hyuck Im, Samsung Medical Centre, Seoul, Korea; Pierfranco Conte, University of Padova and Istituto Oncologico Veneto, Padova, Italy; Miguel Martin, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Tadeusz Pienkowski, Postgraduate Medical Education Center, Warsaw, Poland; Xavier Pivot, University Hospital Jean Minjoz, Besançon, France; Sven Stanzel, Alexander Strasak, Monika Patre, F. Hoffmann-La Roche, Basel, Switzerland; and Paul Ellis, Guys Hospital and Sarah Cannon Research Institute, London, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.67.4887
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.67.4887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455677PMC
January 2017

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

N Engl J Med 2016 11 7;375(18):1738-1748. Epub 2016 Oct 7.

From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1609709DOI Listing
November 2016

Cancer Control in Central and Eastern Europe.

Oncologist 2016 10 8;21(10):1161-1162. Epub 2016 Jul 8.

Division of Medical Oncology, Istituto Oncologico Veneto, University of Padova, Padova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0230DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061535PMC
October 2016

Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.

Lung Cancer 2016 06 25;96:52-5. Epub 2016 Mar 25.

Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IRCCS, via Gattamelata 64, 35128 Padova, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.03.009DOI Listing
June 2016

Endocrine therapy in post-menopausal women with metastatic breast cancer: From literature and guidelines to clinical practice.

Crit Rev Oncol Hematol 2016 Apr 18;100:57-68. Epub 2016 Feb 18.

Department of Clinical and Molecular Medicine, Medical Oncology Division, Sant'Andrea Hospital, "Sapienza" University of Rome, Rome, Italy; IDI-IRCCS, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2016.02.008DOI Listing
April 2016

Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment.

Crit Rev Oncol Hematol 2016 Jan 22;97:220-30. Epub 2015 Aug 22.

Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.08.019DOI Listing
January 2016

Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?

Eur J Nucl Med Mol Imaging 2015 Oct 31;42(11):1648-1655. Epub 2015 May 31.

Medical Oncology 2 Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-015-3088-4DOI Listing
October 2015

Preoperative carboplatin-paclitaxel-bevacizumab in triple-negative breast cancer: final results of the phase II Ca.Pa.Be study.

Ann Surg Oncol 2015 Sep 9;22(9):2881-7. Epub 2015 Jan 9.

Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padua, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4371-0DOI Listing
September 2015

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer.

Oncologist 2015 Sep 5;20(9):1001-10. Epub 2015 Aug 5.

Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Division of Medical Oncology 2, Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy; Division of Oncology, University Hospital, Ferrara, Italy; Division of Pathology, Modena University Hospital, Modena, Italy; Center for Genome Research, University of Modena and Reggio Emilia, Modena, Italy; Unità Operativa Multidisciplinare di Patologia Mammaria, Azienda Ospedaliera Istituti Ospitalieri di Cremona, Cremona, Italy; Division of Medical Oncology, Ramazzini Hospital, Carpi, Italy; Department of Medical Oncology, Azienda Ospedaliera ASMN, IRCCS, Reggio Emilia, Italy; Division of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy; Division of Medical Oncology, University Hospital, Parma, Italy; GlaxoSmithKline, Collegeville, Pennsylvania, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571802PMC
September 2015

A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing.

Oncotarget 2015 Sep;6(28):24884-94

Department of Medical and Surgical Sciences for Children & Adults, Division of Oncology, University-Hospital of Modena and Reggio Emilia, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4670DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694800PMC
September 2015

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma.

Am J Case Rep 2015 Jul 3;16:424-9. Epub 2015 Jul 3.

Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/AJCR.893879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492486PMC
July 2015

Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancer.

Anticancer Res 2015 Apr;35(4):2183-9

Medical Oncology 2, Venetian Oncological Institute, Padova, Italy.

View Article

Download full-text PDF

Source
April 2015

Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas.

Stem Cells 2015 Mar;33(3):859-69

Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.1903DOI Listing
March 2015

Maintenance therapy in epithelial ovarian cancer: from chemotherapy to targeted agents.

Expert Rev Anticancer Ther 2014 Sep 23;14(9):1041-50. Epub 2014 Jun 23.

Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, via Gattamelata 64, 35128, Padova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2014.922415DOI Listing
September 2014

Rare breast cancer subtypes: histological, molecular, and clinical peculiarities.

Oncologist 2014 Aug 26;19(8):805-13. Epub 2014 Jun 26.

Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; and Istituto Oncologico Veneto IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Padova, Italy; Department of Pathology, University Hospital of Padova, Padova, Italy; Department of Medical and Surgical Sciences for Children & Adults, University of Modena and Reggio Emilia, Modena, Italy

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/content/19/8/805.full
Web Search
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2014-0108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122475PMC
August 2014

Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact.

Anticancer Res 2014 Jul;34(7):3657-62

Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy Division of Medical Oncology 2, Venetian Oncology Institution IRCCS, Padova, Italy.

View Article

Download full-text PDF

Source
July 2014

Effects of sulfonylureas on tumor growth: a review of the literature.

Oncologist 2013 16;18(10):1118-25. Epub 2013 Sep 16.

Second Medical Oncology Unit, Istituto Oncologico Veneto, Padua, Italy;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805154PMC
May 2014

Targeting bone metastatic cancer: Role of the mTOR pathway.

Biochim Biophys Acta 2014 Apr 5;1845(2):248-54. Epub 2014 Feb 5.

Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2014.01.009DOI Listing
April 2014

Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.

J Clin Oncol 2014 Apr 3;32(10):1050-7. Epub 2014 Mar 3.

Valentina Guarneri and PierFranco Conte, Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), University of Padova, Padova; Daniele Giulio Generali and Alberto Bottini, U.O. Multidisciplinare di Patologia Mammaria, Azienda Ospedaliera Istituti Ospitalieri di Cremona, Cremona; Antonio Frassoldati, University Hospital, Ferrara; Fabrizio Artioli and Katia Cagossi, Ramazzini Hospital, Carpi; Corrado Boni and Giancarlo Bisagni, Azienda Ospedaliera Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia; Luigi Cavanna, Hospital of Piacenza, Piacenza; Enrico Tagliafico, Enrica Roncaglia, and Simona Nuzzo, Center for Genome Research, University of Modena and Reggio Emilia; Antonino Maiorana, Federico Piacentini, Guido Ficarra, and Stefania Bettelli, Modena University Hospital, Modena, Italy; Ramona Swaby and Catherine Ellis, GlaxoSmithKline, Upper Providence, PA; and Clare Holford, GlaxoSmithKline, Stockley Park, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.4737DOI Listing
April 2014

A Bill of Rights for patients with cancer in Europe.

Lancet Oncol 2014 Mar 4;15(3):258-60. Epub 2014 Feb 4.

Centre for Cancer Research and Cell Biology and Institute of Health Sciences, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast BT9 7BL, UK.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S147020451370552
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(13)70552-7DOI Listing
March 2014

Interpreting cancer biology: refining our therapeutic algorithm in breast cancer.

Oncologist 2013 ;18(4):e8-10

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639541PMC
December 2013

Fatal oxaliplatin-induced thrombotic thrombocytopenic purpura: a case report.

Clin Colorectal Cancer 2013 Dec;12(4):294-6

Division of Oncology 2, Istituto Oncologico Veneto (IOV-IRCCS), Padova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2013.09.002DOI Listing
December 2013

Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance.

Apoptosis 2013 Oct;18(10):1274-89

Division of Pediatric Oncology, Hematology and Marrow Transplantation, Department of Medical and Surgical Sciences for Children & Adults, University of Modena and Reggio Emilia, Modena Policlinic, Modena, 41100, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10495-013-0878-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775159PMC
October 2013

Body mass index and prognosis of metastatic breast cancer patients receiving first-line chemotherapy.

Cancer Epidemiol Biomarkers Prev 2013 Oct 14;22(10):1862-7. Epub 2013 Aug 14.

Authors' Affiliations: Divisions of Medical Oncology and Internal Medicine; Office of the Scientific Director, Galliera Hospital; IRCCS San Martino-IST, Genoa; IRCCS-IRST, Romagna Cancer Institute, Meldola (FC); and University of Padova, Padova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0595DOI Listing
October 2013

Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood.

Biomed Res Int 2013 31;2013:901821. Epub 2013 Mar 31.

Division of Oncology, Department of Medical and Surgical Sciences of Children & Adults, University Hospital of Modena and Reggio Emilia, Via del Pozzo 71, 41100 Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/901821DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626323PMC
September 2013

Relapsed triple-negative breast cancer: challenges and treatment strategies.

Drugs 2013 Aug;73(12):1257-65

Medical Oncology 2, Istituto Oncologico Veneto IRCCS, University of Padova, Via Gattamelata 64, 35128 Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-013-0091-6DOI Listing
August 2013

MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential.

Adv Biochem Eng Biotechnol 2013;130:209-66

Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, Via del Pozzo, 71, 41100, Modena, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/10_2012_150
Publisher Site
http://dx.doi.org/10.1007/10_2012_150DOI Listing
January 2013

The next generation of biologic agents: therapeutic role in relation to existing therapies in metastatic breast cancer.

Clin Breast Cancer 2012 Jun;12(3):157-66

Department of Oncology, Hematology, and Respiratory Diseases, University of Modena, Reggio Emilia, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2012.03.005DOI Listing
June 2012

Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma.

J Clin Oncol 2012 Feb 27;30(6):e76-8. Epub 2011 Dec 27.

Department of Oncology, Hematology, and Respiratory Diseases, University of Modena and Reggio Emilia Hospital, via del Pozzo 71, 41124 Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.38.7886DOI Listing
February 2012

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer.

Expert Opin Pharmacother 2012 Feb 21;13(3):395-406. Epub 2012 Jan 21.

University of Modena and Reggio Emilia, University Hospital, Department of Oncology, Hematology and Respiratory Diseases , Via del Pozzo 71, Modena 41100 , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2012.651127DOI Listing
February 2012